DKK1
Showing 1 - 25 of 116
Endometrial Cancer Trial in Houston (DKN-01, Pembrolizumab)
Not yet recruiting
- Endometrial Cancer
-
Houston, TexasM D Anderson Cancer Center
Feb 27, 2023
Monoclonal Gammopathy, Smoldering Myeloma, Myeloma Trial in Cleveland (DKK1)
Not yet recruiting
- Monoclonal Gammopathy
- +2 more
- DKK1
-
Cleveland, Ohio
- +1 more
Nov 29, 2021
Osteoporosis, Postmenopausal, Periodontitis Trial (Phase 1 periodontal therapy, Bisphosphonate therapy)
Completed
- Osteoporosis, Postmenopausal
- Periodontitis
- Phase 1 periodontal therapy
- Bisphosphonate therapy
- (no location specified)
Feb 18, 2021
Multiple Myeloma Treated With Intravenous Bisphosphonate in
Recruiting
- Multiple Myeloma
- Blood and urine collection
-
Paris, FranceNecker Hospital, Adult haematology department
Oct 1, 2021
Multiple Myeloma, Renal Insufficiency Trial in Spain, United Kingdom, United States (BHQ880, BHQ880 Placebo, bortezomib)
Completed
- Multiple Myeloma
- Renal Insufficiency
- BHQ880
- +3 more
-
Chicago, Illinois
- +7 more
Dec 11, 2020
Acute Kidney Injury - Biomarkers in Major Abdominal Surgery
Completed
- Acute Kidney Injury
- Urinary Biomarkers (NGAL, DKK-3, IGFBP-7/TIMP-2, KIM-1)
-
Guildford, Surrey, United KingdomRoyal Surrey County Hospital
Oct 5, 2020
Role of Osteocytes in Myeloma Bone Disease
Recruiting
- Multiple Myeloma
-
Indianapolis, Indiana
- +1 more
Feb 8, 2022
Osteoporosis and Fragility Fractures Among SLE Patients.
Recruiting
- Lupus Erythematosus, Systemic
- DXA
- +2 more
-
Verona, ItalyAOUI Verona - UOC Reumatologia
Oct 18, 2022
Knee Osteoarthritis Trial (Blueberry powder supplement, Maltodextrin supplementation)
Not yet recruiting
- Knee Osteoarthritis
- Blueberry powder supplement
- Maltodextrin supplementation
- (no location specified)
Mar 13, 2023
Osteoporosis, Postmenopausal Trial (Zoledronate, Placebo)
Not yet recruiting
- Osteoporosis, Postmenopausal
- Zoledronate
- Placebo
- (no location specified)
Dec 15, 2022
Bone in Pediatric Gaucher Disease Related to Bone Pathology in
Recruiting
- Gaucher Disease
- Bone Diseases
-
Fairfax, VirginiaLysosomal and Rare disorder research and treatment center
Nov 6, 2023
Ischemic Stroke, Acute, Ischemia-reperfusion Injury, Cerebral Edema Trial in Dongguan, Guangzhou (enzyme-linked immunosorbent
Recruiting
- Ischemic Stroke, Acute
- +2 more
- enzyme-linked immunosorbent assay(ELISA)
-
Dongguan, Guangdong, China
- +1 more
Oct 15, 2022
GDM, Gestational Diabetes, Nutritional and Metabolic Diseases Trial in Herlev (Dietary treatment)
Not yet recruiting
- GDM
- +4 more
- Dietary treatment
-
Herlev, DenmarkSteno Diabetes Center Copenhagen
Nov 8, 2023
DKK3 for Prognosis and Monitoring of GFR Loss in Heart Failure
Recruiting
- Heart Failure
- Chronic Kidney Diseases
- No intervention
-
Giessen, Hessen, GermanyUniversity Clinic Giessen and Marburg - Campus Giessen
May 18, 2022
Osteoporosis, Postmenopausal Trial in Clermont-Ferrand (Cohort follow-up)
Recruiting
- Osteoporosis, Postmenopausal
- Cohort follow-up
-
Clermont-Ferrand, FranceCHU de Clermont-Ferrand
Oct 6, 2022
Axial Spondyloarthritis Trial in Halmstad (High intensity interval training (HIIT), Control group)
Recruiting
- Axial Spondyloarthritis
- High intensity interval training (HIIT)
- Control group
-
Halmstad, Halland, SwedenHalmstad University
Mar 12, 2023
Catheter Blockage Trial in Odense (UroTainer®, Saline)
Enrolling by invitation
- Catheter Blockage
- UroTainer®
- Saline
-
Odense, DenmarkOdense University Hospital
Mar 7, 2023
Chronic Kidney Disease, Diabetes, Type 2, Hypertension Trial in Genova (Dapagliflozin 10mg Tab, Placebo)
Recruiting
- Chronic Kidney Disease
- +2 more
- Dapagliflozin 10mg Tab
- Placebo
-
Genova, GE, ItalyIRCCS Ospedale Policlinico San Martino
Aug 10, 2023
Langerhans Cell Histiocytosis Trial in Athens (Denosumab 70 MG/ML [Xgeva])
Completed
- Langerhans Cell Histiocytosis
- Denosumab 70 MG/ML [Xgeva]
-
Athens, Attiki, Greece251 Hellenic AirForce & VA General Hospital, Dpt of Endocrinolog
Oct 1, 2022
Osteoporosis, Postmenopausal Trial in Clermont-Ferrand (Follow-up of patients with postmenopausal osteoporosis, with or without
Recruiting
- Osteoporosis, Postmenopausal
- Follow-up of patients with postmenopausal osteoporosis, with or without fractures, requiring initiation of injectable bisphosphonate therapy as part of their usual care
- Follow-up of patients with postmenopausal osteoporosis, fractured or not, requiring initiation of injectable bisphosphonate therapy as part of care with magnesium supplementation
-
Clermont-Ferrand, FranceCHU clermont-ferrand
Jun 29, 2022